Evaluation of Human and Simian Immunodeficiency Virus Plaque and Neutralization Assays

References

1. Cheng-Mayer C., Homsy J., Evans L. A., Levy J. A. 1988; Identification of HIV subtypes with distinct patterns of sensitivity to serum neutralization. Proceedings of the National Academy of SciencesU.S.A 85:2815–2819
   [Google Scholar]
2. Clapham P. R., Weiss R. A., Dalgleish A. G., Exley M., Whitbay D., Hogg N. 1987; Human immunodeficiency virus infection of monocytic and T-lymphotropic cells: receptor modulation and differentiation induced by phorbol ester. Virology 158:44–51
   [Google Scholar]
3. Clapham P. R., Weber J. N., Whitby D., McIntosh K., Dalgleish A. G., Maddon P. J., Deen K. C., Sweet R. W., Weiss R. A. 1989; Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature, London 337:368–370
   [Google Scholar]
4. Clavel F. D., Guetard F., Brun-Vezinet S., Laurent A. G., Dauguet C., Katlama C., Rouzioux C., Klatzmann D., Champalimaud J. L., Montagnier L. 1986; Isolation af a new human retrovirus from West African patients with AIDS. Science 233:343–346
   [Google Scholar]
5. Dalgleish A. G., Beverley P. C. L., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. 1984; The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature, London 312:763–767
   [Google Scholar]
6. Dalgleish A. G., Chanh T. C., Kennedy R. C., Kanda P., Clapham P. R., Weiss R. A. 1988; Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology 165:209–215
   [Google Scholar]
7. Downing R. G., Eglin R. P., Bayley A. C. 1984; African Kaposi’s sarcoma and AIDS. Lancet ii:478–480
   [Google Scholar]
8. Foley G. E., Lazarus H., Farber S., Geren-Uzmain B., Boone B. A., McCarthy R. E. 1965; Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522–529
   [Google Scholar]
9. Harada S., Koyanagi Y., Yamamoto N. 1985; Infection of HTLV-III/LAV in HTLV-I carrying cells MT2 and MT4 and application in a plaque assay. Science 229:563–566
   [Google Scholar]
10. Harada S., Purtilo D., Koyanagi K., Sonnabend J., Yamamoto N. 1986; Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV). Journal of Immunological Methods 92:177–181
    [Google Scholar]
11. Harada S., Kobayasi N., Koyanagi N. 1987; Clonal selection of HIV: serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-IIIB, LAV and ARV). Virology 158:447–451
    [Google Scholar]
12. Linsley P. S., Ledbetter J. A., Kinney-Thomas E., Hu S. L. 1988; Effects of anti-gpl20 monoclonal antibodies on CD4 receptor binding by the env protein of HIV-1. Journal of Virology 62:3695–3702
    [Google Scholar]
13. Looney D. J., Fisher A. G., Putney S. D., Rusche J. R., Redfield R. R., Burke D. S., Gallo R. C., Wong-Staal F. 1988; Type-restricted neutralization of molecular clones of HIV. Science 241:357–359
    [Google Scholar]
14. Matthews T. J., Langlois A. J., Robey W. G., Chang N. T., Gallo R. C., Fischinger P. J., Bolognesi D. P. 1986; Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proceedings of the National Academy of SciencesU.S.A 83:9709–9713
    [Google Scholar]
15. Minowada J., Ohnuma T., Moore G. E. 1972; Rosette-forming human lymphoid celllines. I. Establishment and evidence for origin of thymus-derived lymphocytes. Journal of the National Cancer Institute 49:891–895
    [Google Scholar]
16. Montefiori D. C., Robinson W. E., Schuffman S. S., Mitchell W. M. 1988; Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. Journal of Clinical Microbiology 26:231–235
    [Google Scholar]
17. Nara P. L., Hatch W. C., Dunlop N. M., Robey W. G., Arthur L. O., Gonda M. A., Fischinger P. J. 1987; Simple, rapid, quantitative, syncytium-forming micro-assay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Research and Human Retroviruses 3:283–302
    [Google Scholar]
18. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. 1984; A method for detection, isolation, and continuous production of cytopathic human T-lymphotropic retroviruses of the HTLV family (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
    [Google Scholar]
19. Prince A. M., Pascual D., Kosolapov L. B., Kurokawa D., Baker L., Rubinstein P. 1987; Prevalence, clinical significance and strain specificity of neutralizing antibody to the human immunodeficiency virus. Journal of Infectious Diseases 156:268–272
    [Google Scholar]
20. Robert-Guroff M., Brown M., Gallo R. C. 1985; HTLV-III neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature, London 316:72–74
    [Google Scholar]
21. Rosen C. A., Sodroski J. G., Campbell K., Haseltine W. A. 1986; Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes. Journal of Virology 57:379–384
    [Google Scholar]
22. Skinner M. A., Langlois A. J., McDanal C. B., McDougal J. S., Bolognesi D. P., Matthews T. J. 1988; Neutralizing antibodies to an immunodominant envelope sequence do not prevent gpl20 binding to CD4. Journal of Virology 62:4195–4200
    [Google Scholar]
23. Smith S. D., Shatsky M., Cohen P. S., Warnke R., Link M. P., Glader B. E. 1984; Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Research 44:5657–5660
    [Google Scholar]
24. Sodroski J. G., Rosen C. A., Haseltine W. A. 1984; Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381–385
    [Google Scholar]
25. Taylor H. P., Dimmock N. J. 1985; Mechanisms of neutralization of influenza virus by IgM. Journal of General Virology 66:903–907
    [Google Scholar]
26. Weiss R. A., Clapham P. R., Cheingsong-Popov R., Dalgleish A. G., Carne C. A., Weller I. V. D., Tedder R. S. 1985; Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature, London 316:69–72
    [Google Scholar]
27. Weiss R. A., Clapham P. R., Weber J. N., Dalgleish A. G., Lasky L. A., Berman P. W. 1986; Variable and conserved neutralization antigens of human immunodeficiency virus. Nature, London 324:572–575
    [Google Scholar]
28. Zagury D., Bernard J., Cheynier R., Desportes I., Leonard R., Fouchard M., Reveil B., Ittele D., Lurhuma Z., Mbayo K., Wane J., Salaun J., Goussard B., Dechazal L., Burny A., Nara P., Gallo R. C. 1988; A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS. Nature, London 332:728–731
    [Google Scholar]